Yunsheng Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yunsheng Chen has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Damla Arslan-Acaroz
Afyon Kocatepe Universitesi
1 shared publication - Fatih Ramazan İsTanbullugil
KIRGIZİSTAN-TÜRKİYE MANAS ÜNİVERSİTESİ, VETERİNER FAKÜLTESİ
1 shared publication - Gaspar Ros
Universidad de Murcia
1 shared publication Jiajia Zhu
China Agricultural University
1 shared publication- Jiajia Zhu
Key Laboratory of Prevention and Control Agents for Animal Bacteriosis (Ministry of Agriculture and Rural Affairs), Hubei Provincial Key Laboratory of Animal Pathogenic Microbiology, Institute of Animal Husbandry and Veterinary, Hubei Academy of Agricultural Sciences, Wuhan 430064, China
1 shared publication Kui Zhu
China Agricultural University
1 shared publication
Latest Publications
- Open Access
- 28 January 2025
- Published by Wiley
Population dynamics of Haemophilus driven by Bacillus-derived metabolites
Antibacterial efficacy is significantly affected by the intra- and interspecies interactions. The ubiquitous reciprocal effects in the polymicrobial community especially in polymicrobial infections are crucial to understanding how pathogens adapt and evolve in an ecological context. The parasitism and exploitation behaviors driving the population dynamics of pathogens provide targets to tackle the spread of metabolic dependence of pathogens. In this study, we present the unique vulnerability to the cross-feeding between pathogens and diverse bacteria. Here, we focused on the population dynamics of Haemophilus and Bacillus within the context of bacterial communities, and explored the functional role of Bacillus-derived metabolites in both positive and negative interactions with Haemophilus. We found that Bacillus produces the reduced form of extracellular nicotinamide adenine dinucleotide (NADH) to facilitate the growth of Haemophilus, when nutrients are rich. In turn, the sharp decreased redox state in Bacillus triggers the synthesis of bactericidal compounds to sacrifice Haemophilus, facilitating the survival of Bacillus under restricted resources. Our work demonstrates that the elucidation of how interspecies interactions not only provides new insights into the stochastic progression of polymicrobial infections but also contributes to effective antibacterial prevention and intervention strategies.
- 28 January 2025
- Published by Wiley
Open AccessPopulation dynamics of Haemophilus driven by Bacillus-derived metabolites
Antibacterial efficacy is significantly affected by the intra- and interspecies interactions. The ubiquitous reciprocal effects in the polymicrobial community especially in polymicrobial infections are crucial to understanding how pathogens adapt and evolve in an ecological context. The parasitism and exploitation behaviors driving the population dynamics of pathogens provide targets to tackle the spread of metabolic dependence of pathogens. In this study, we present the unique vulnerability to the cross-feeding between pathogens and diverse bacteria. Here, we focused on the population dynamics of Haemophilus and Bacillus within the context of bacterial communities, and explored the functional role of Bacillus-derived metabolites in both positive and negative interactions with Haemophilus. We found that Bacillus produces the reduced form of extracellular nicotinamide adenine dinucleotide (NADH) to facilitate the growth of Haemophilus, when nutrients are rich. In turn, the sharp decreased redox state in Bacillus triggers the synthesis of bactericidal compounds to sacrifice Haemophilus, facilitating the survival of Bacillus under restricted resources. Our work demonstrates that the elucidation of how interspecies interactions not only provides new insights into the stochastic progression of polymicrobial infections but also contributes to effective antibacterial prevention and intervention strategies.
- Open Access
- 15 August 2023
- Published by Springer Nature in One Health Advances
- Vol. 1 (1) , 1-22
Mechanisms of probiotic Bacillus against enteric bacterial infections
Gastrointestinal infection is a leading cause of gut diseases attracting global health concerns. The emerging antimicrobial resistance in enteric pathogens drives the search of viable and renewable alternatives to antibiotics for the health of both human beings and animals. Spore-forming probiotic Bacillus have received extensively interests for their multiple health benefits, including the restoration of microbiota dysbiosis and the reduction of drug-resistant pathogens. These promising benefits are mainly attributed to the activity of structurally diverse Bacillus-derived metabolites, such as antibacterial compounds, short-chain fatty acids, and other small molecules. Such metabolites show the capacity to directly target either the individual or community of bacterial pathogens, and to potentiate both host cells and gut microbiota. The better understanding of the mechanisms by which probiotic Bacillus and the metabolites modulate the metabolism of hosts and microbiota will advance the screening and development of probiotic Bacillus. In this review, we discuss the interaction among probiotic Bacillus, microbiota and host, and summarize the Bacillus-derived metabolites that act as key players in such interactions, shedding light on the mechanistic understanding of probiotic Bacillus against enteric bacterial infections.
- 15 August 2023
- Published by Springer Nature in One Health Advances
- Vol. 1 (1) , 1-22
Open AccessMechanisms of probiotic Bacillus against enteric bacterial infections
Gastrointestinal infection is a leading cause of gut diseases attracting global health concerns. The emerging antimicrobial resistance in enteric pathogens drives the search of viable and renewable alternatives to antibiotics for the health of both human beings and animals. Spore-forming probiotic Bacillus have received extensively interests for their multiple health benefits, including the restoration of microbiota dysbiosis and the reduction of drug-resistant pathogens. These promising benefits are mainly attributed to the activity of structurally diverse Bacillus-derived metabolites, such as antibacterial compounds, short-chain fatty acids, and other small molecules. Such metabolites show the capacity to directly target either the individual or community of bacterial pathogens, and to potentiate both host cells and gut microbiota. The better understanding of the mechanisms by which probiotic Bacillus and the metabolites modulate the metabolism of hosts and microbiota will advance the screening and development of probiotic Bacillus. In this review, we discuss the interaction among probiotic Bacillus, microbiota and host, and summarize the Bacillus-derived metabolites that act as key players in such interactions, shedding light on the mechanistic understanding of probiotic Bacillus against enteric bacterial infections.